期刊文献+

麦冬多糖单次静脉注射在大鼠体内组织分布 被引量:4

Distribution of Polysaccharide MDG-1 after Single Intravenous Dose in Rats
下载PDF
导出
摘要 目的建立柱前荧光衍生-高效凝胶色谱(HPGPC)法测定大鼠组织样品中麦冬多糖的方法,并研究麦冬多糖在大鼠体内的分布特点和规律。方法将SD大鼠单次静脉注射麦冬多糖50mg·kg-1后,于5,10,30,60min取各组织,用HPGPC法测定药物浓度。结果大鼠心、肝、脾、肺、胃、肾、脑的AUC分别为3.270,2.031,2.303,6.178,4.963,214.571,0.613μg·h·mL-1。结论绝大多数药物聚集在肾脏,并以尿的形式排泄,其他组织中含药量分布顺序从高到低依次为肺、胃、心、脾、肝、脑。 Objective To establish a method for measuring polysaccharide MDG-1 from tissues by pre-column FITC labeled-HPGPC and investigating the distribution of it in rat tissues. Methods Various tissues were obtained at 5,10,30 and 60 min, respectively, after a single intravenous administration of 50 mg · kg^-1 polysaccharide MDG-1. The concentration of MDG- 1 in samples were subsequently determined by HPGPC. Results Most of MDG-1 was readily accumulated in kidneys and excreted in urine. The distribution sequence of different tissues ranking from high to low was lung, stomach, heart, spleen, liver, brain. Conclusion MDG-1 could exert anti-myocardial ischemia effects directly on the target organ.
出处 《医药导报》 CAS 2008年第5期497-500,共4页 Herald of Medicine
基金 上海市青年科技启明星计划资助项目(项目编号:07QA14050)
关键词 麦冬多糖 柱前荧光衍生-高效凝胶色谱法 组织分布 抗心肌缺血 Polysaccharide MDG-1 Precolumn FITC labeled-HPGPC method Tissue distribution Anti-myocardial ischemic activity
  • 相关文献

参考文献7

二级参考文献13

  • 1徐德生,冯怡,周跃华,张晓晨,林晓,邓海林.麦冬多糖中抗急性心肌缺血活性部位研究[J].中成药,2004,26(10):832-837. 被引量:59
  • 2薛惟建,鞠彪,王淑如,陈琼华.银耳多糖和木耳多糖对四氧嘧啶糖尿病小鼠高血糖的防治作用[J].中国药科大学学报,1989,20(3):181-183. 被引量:38
  • 3Huang Y,Anal Biochem,1996年,240卷,227页
  • 4Sawada S, Yokokura T. Synthesis of CPT-11 [J]. Ann NY Acad Sci, 1996,803:13-28.
  • 5Verschraegen CF, Natelson EA, Giovanella BC, et al. A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor [J]. Anti Cancer Drugs, 1998, 9(1):36-44.
  • 6Ahmed AE, Jacob S, Giovanella BC, et al. Comparative disposition of the antineoplastic agent 9-nitrocamptothecin and the inactive isomer 12-nitrocamptothecin in CASE-bearing nude mice: effect of route of administration on tissue distribution [J]. Cancer Chemother Pharmacol, 1997,41(1):29-36.
  • 7Koshkina NV, Gilbert BE, Waldrep JC, et al. Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice [J]. Cancer Chemother Pharmacol, 1999,44(3):187-192.
  • 8Stehlin JS Jr, Natelson EA, Hinz HR, et al. Phase I clinical trial and pharmacokinetics resulted with oral administration of 20(S)-camptothecin [A]. Potmesil M. Camptothecins: New Anticancer Agent [M]. Boca Raton: CRC Press, 1995.59-65.
  • 9Ahmed AE, Jacob S, Giovanella BC, et al. Influence of route of administration of 3H-camptothecin distribution and tumor uptake in CASE-bearing nude mice: whole-body autoradiographic studies [J]. Cancer Chemother Pharmacol, 1996,39(1-2):122-130.
  • 10齐春会,张永祥,乔善义,陈保文,姚新生,周金黄.六味地黄多糖体外对正常及衰老小鼠脾细胞免疫功能的影响[J].中国药理学通报,1999,15(2):157-160. 被引量:55

共引文献61

同被引文献104

引证文献4

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部